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The B vitamins are components of one-carbon metabolism (OCM) that contribute to DNA synthesis and methylation. Homocysteine,
a by-product of OCM, has been associatedwith coronary heart disease, stroke and neurological disease. To investigate genetic factors that
affect circulating vitamin B6, vitamin B12, folate and homocysteine, a genome-wide association analysis was conducted in the
InCHIANTI (N ¼ 1175), SardiNIA (N ¼ 1115), and BLSA (N ¼ 640) studies. The top loci were replicated in an independent sample of
687 participants in the Progetto Nutrizione study. Polymorphisms in the ALPL gene (rs4654748, p ¼ 8.30 3 1018) were associated
with vitamin B6 and FUT2 (rs6022662, p¼ 2.833 1020) with vitamin B12 serum levels. The association ofMTHFR, a gene consistently
associated with homocysteine, was conﬁrmed in this meta-analysis. The ALPL gene likely inﬂuences the catabolism of vitamin B6 while
FUT2 interferes with absorption of vitamin B12. These ﬁndings highlight mechanisms that affect vitamin B6, vitamin B12 and homo-
cysteine serum levels.One-carbonmetabolism (OCM) is a process whereby folate
transfers one-carbon groups in a range of biological
processes including DNA synthesis, methylation, and
homocysteine metabolism.1,2 Water-soluble B vitamins
folate, vitamin B6, and vitamin B12 play key roles as
enzyme cofactors or substrates in OCM. Patients with deﬁ-
ciencies in these vitamins can develop anemia (MIM
170900 and 261100) and, in the case of vitamin B12 deﬁ-
ciency, neurological problems. Subclinical deﬁciencies
during pregnancy have been linked with neural tube
defects (NTD [MIM 601634]).3,4 In adults, subclinical B
vitamin deﬁciency has been associated with increased
risk of coronary artery disease (CAD [MIM 607339])5–8
and some cancers such as colorectal cancer (CRC [MIM
114500]).9,10
The exact mechanism that links B vitamins with human
health is unknown, but is thought to involve the OCM
metabolic pathways.1,11 One of the main hypotheses for
the protective effect of B vitamins on CAD is that folate,
vitamin B12, and vitamin B6 deﬁciencies increase the
production and decrease the catabolism of homocysteine,
which is an independent risk factor for CAD.12–14 Homo-
cysteine affects various proatherogenic processes including
inﬂammation, thrombosis, endothelial dysfunction, and
vascular smoothmuscle cell proliferation.15,16 Folate insuf-
ﬁciency alters gene expression through changes inmethyl-
ation pattern of DNA and histones.17–19The study of genetic variants that affect circulating levels
of B vitamins is important for understanding the interplay
of diet, genetics, and human health. Circulating levels of B
vitamins and homocysteine are at least in part genetically
determined. The most-studied polymorphism is the
677T)C (rs1801133) in exon 5 of the 5,10-methylenete-
trahydrofolate reductase (MTHFR [MIM 607093]) gene.
The 677T variant results in an thermolabile enzyme that
is less effective in the conversion of 5,10-methylenetetra-
hydrofolate to 5-methyltetrahydrofolate.20 Accordingly,
individuals with the 677T variant have higher homocys-
teine concentrations as well as lower genomic DNA meth-
ylation.21,22 In addition to MTHFR, genetic variations in
other genes have been linked to B vitamin and homocys-
teine concentrations, although results have been inconsis-
tent.1,23 The goal of the present study was to conduct
a genome-wide investigation to identify SNPs associated
with differential concentrations of folate, vitamin B12,
vitamin B6, and homocysteine in the InCHIANTI study
from the Chianti region in Tuscany, Italy;24,25 SardiNIA
study from Ogliastra province of Sardinia, Italy;26 and
Baltimore Longitudinal Study of Aging (BLSA) based in
the Baltimore-Washington DC area.27 The results from the
genome-wide association (GWA) were examined in the
Progetto Nutrizione study based in Tuscany, Italy.28
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Table 1. Descriptive Characteristics of InCHIANTI, SardiNIA, BLSA, and Progetto Nutrizione Study
Studies InCHIANTI BLSA SardiNIA Progetto Nutrizione
N 1178 641 1115 686
Vitamin B6 (ng/mL) 7.5 (7.8) – – 12.7 (10.2)
Vitamin B12 (pg/mL) 467.4 (330.4) 487.2 (240.5) 404.1 (278.2) 387.8 (194.8)
Folic acid (ng/mL) 3.3 (2.0) 15.8 (8.6) 3.4 (1.7) 5.9 (2.9)
Homocysteine (mmol/L) 15.2 (6.9) 10.2 (5.3) 11.7 (5.1) 11.0 (5.5)
Age (years) 68.1 (15.5) 68.3 (15.5) 44.7 (18.4) 47.0 (12.7)
BMI (kg/m2) 27.2 (4.2) 27.2 (4.2) 25.5 (4.7) 24.9 (4.3)
% Males (N) 44.4% (523) 54.0% (346) 42.2% (470) 40.0% (276)
% Smokers (N) 18.9% (222) 3.7% (24) 19.4% (216) 40.2% (276)
Means (SD) or % (N).BLSA, and Progetto Nutrizione studies (Table 1). Folic acid
concentration was higher in the BLSA (which is U.S. based)
compared to the Italian studies, reﬂecting fortiﬁcation
policies in the United States. For the same reason, homo-
cysteine concentration was lowest in the BLSA even
though the individuals in this study, on average, were
the oldest in the four studies.
Genome-wide signiﬁcant associations were observed for
vitamin B6, B12, and homocysteine concentrations.
Vitamin B6 was only measured in the InCHIANTI study,
thus the GWA of 484,115 autosomal SNPs was assessed
with a Bonferroni corrected p value threshold of 1 3 107
(Figure 1A and Figure S1 available online). Three SNPs that
met the threshold were located in a region with high
linkage disequilibrium (LD) including the neuroblastoma
breakpoint family, member 3 (NBPF3 [MIM 612367]),
and ~12–50 kb upstream of the tissue nonspeciﬁc alkaline
phosphatase (ALPL [MIM 171760]) gene (Figure S2). The
most signiﬁcant SNP was rs4654748 (p ¼ 1.21 3 108),
in which the presence of the C allele was associated with
1.38 ng/mL lower vitamin B6 concentrations (Table 2).
This association was replicated in the Progetto Nutrizione
study (rs4654748; ALPL p ¼ 2.08 3 1011). A sample-size-
weighted meta-analysis across the two studies resulted in
a p value of 8.3 3 1018 and 1.45 ng/mL lower vitamin
B6 per copy of the C allele.
Mutations in the ALPL gene cause hypophosphotasia
(MIM 241510, 231500, and 146300), an inborn error of
metabolism characterized by low or complete absence of
alkaline phosphatase (ALP) activity. The clinical manifesta-
tion of hypophosphatasia is highly variable, ranging from
a lethal perinatal form to a more moderate adult form pre-
senting with bone abnormalities.29,30 One characteristic of
hypophosphatasia is the accumulation of phospho
compounds including vitamin B6. All of the hypophopha-
tasia mutations identiﬁed, many of which are missense
mutations, lie within the ALPL gene.30 In a recent meta-
analysis that included the InCHIANTI study, rs1780324
within the ALPL gene region was the top signal associated
with ALP concentration.31 This SNP was one of the top-
three SNPs in the vitamin B6 analysis in the current study
and is in LD with the most signiﬁcant SNP, rs4654748
(r2 ¼ 0.6). When the regression model was conditioned478 The American Journal of Human Genetics 84, 477–482, April 10on rs4654748, rs1780324 was no longer signiﬁcantly
associated with vitamin B6 (p ¼ 0.358), indicating that
these two SNPs represent the same locus. In addition,
when ALP levels are included in the regression model,
the associations of both rs4654748 (p ¼ 0.0331) and
rs1780324 (p ¼ 0.019) with vitamin B6 were no longer
signiﬁcant. This indicates that the association of the two
ALPL gene SNPs with vitamin B6 is mediated by ALP.
Mechanistically, ALP is the major enzyme involved in
the clearance of vitamin B6,32 and therefore the lower
vitamin B6 in C allele carriers most likely results from
more efﬁcient clearance of the vitamin.
Vitamin B12, folate, and homocysteine concentrations
were available for GWA in InCHIANTI, SardiNIA, and
BLSA. To conduct a meta-analysis of the results from
these three studies, which were genotyped with different
platforms (Affymetrix and Illumina), we imputed ~2.5
million SNPs with MACH using the HapMap CEPH
sample as reference.33 The SNPs that passed quality
control (MAF > 1%, r2hat > 0.3) were used to conduct
a GWA analysis in each study. For the meta-analysis, an
arbitrary reference allele is selected and a z statistic
summarizing the magnitude and direction of effect rela-
tive to the reference allele is weighted by the square
root of the sample size of each study. A ﬁxed-effects
inverse-variance method was used for calculating the
effect sizes. For the meta-analysis, a Bonferroni corrected
p value threshold of 5 3 108 was considered to be
genome-wide signiﬁcant.
One locus reached genome-wide signiﬁcance in the
meta-analysis of vitamin B12 concentrations (Figure 1B;
Figure S1; Table 2). The top SNP in this locus, rs6022662
(pmeta ¼ 2.43 3 1012), mapped to exon 2 of the fucosyl-
transferase 2 (FUT2) gene (Figure S2A). The presence of
the A allele was associated with 44.2 pg/mL higher vitamin
B12 concentrations. This is the same SNP reported in
a recent GWA analysis in 2717 women in the Cancer
Genetic Markers of Susceptibility projects and the Nurses’
Health Study.34 Polymorphisms in FUT2 determine the
human secretor (Se) blood group through the expression
of a1,2-fucosyltransferase that mediates the fucosylation
of oligosaccharides to form H type 1 and 2 antigens.35,36
These H antigens mediate the adhesion of various gastric, 2009
pathogens such as Helicobactor pylori to the gastric and
duodenal mucosal.36–38 Overgrowth of gastric bacteria,
such as with H. pylori, has been associated with vitamin
B12 deﬁciency.39,40 Interestingly, rs602662 has been iden-
tiﬁed in nonsecretor status, or the absence of H antigens, in
individuals fromNorthern Portugal.41 The reduced activity
of the FUT2 enzyme with the A allele may decrease suscep-
tibility to bacterial infection and indirectly lower the risk of
vitamin B12 malabsorption, thereby resulting in higher
vitamin B12 concentrations in A allele carriers.
The second- and third-top SNPs for vitamin B12 analysis
did not reach genome-wide signiﬁcance but were mapped
to genes involved in the absorption and transport of
vitamin B12. These were rs11254363 in intron 52 of the
intrinsic factor—cobalamin receptor, cubilin (CUBN
[MIM 602997]) gene (pmeta ¼ 7.24 3 108; Table 2,
Figure S2) and rs526934 in intron 8 of the transcobalamin
I (TCN1 [MIM 189905]) gene (pmeta ¼ 8.33 3 107; Table
2, Figure S2). Mutations in CUBN cause a rare autosomal-
recessive disorder termed megaloblastic anemia 1 (MGA
[OMIM 261100]), characterized by juvenile pernicious
anemia.42,43 Mutations in TCN1 result in transcobalamin
I deﬁciency (OMIM 193090), characterized by low vitamin
B12. These SNPs, however, were not replicated in the Pro-
getto nutrizione study. There is evidence for heterogeneity
among studies for rs11254363 (c2 ¼ 9.24, p ¼ 0.03)
but not rs526934 (X2 ¼ 5.37, p ¼ 0.15). Subjects in the
A
B
C
Figure 1. Genome-wide Scans of Plasma
Vitamin B12 and B6 in the InCHIANTI
Study on Aging
(A) Genome-wide associations of plasma
vitamin B6 graphed by chromosome
position and log10 p value. The most
significant variant was in the ALPL and
NBPF3 genes on chromosome 1.
(B) Genome-wide associations of plasma
vitamin B12 graphed by chromosome
position and log10 p value. The most
significant variant was in the FUT2 gene
on chromosome 19. The next genes of
interested included CUBN gene on chromo-
some 10 and TCN1 on chromosome 11.
(C) Genome-wide associations of plasma
homocysteine graphed by chromosome
position and log10 p value. The most
significant variant was in the MTHFR gene
on chromosome 1. The second significant
region was in the SYT9 gene on chromo-
some 11.
Progetto nutrizione study come from
a similar source population as the
InCHIANTI study; thus it is difﬁcult
to identify any factor contributing to
the observed heterogeneity and warrants further investi-
gation.
In the meta-analyses of homocysteine concentrations,
rs1801133 reached genome-wide signiﬁcance (pmeta ¼
4.36 3 1013; Figure 1C; Figure S1). This SNP is the C677T
polymorphism in the MTHFR gene (Figure S4). Although
this polymorphism was highly associated with homocys-
teine concentrations in both InCHIANTI (b ¼ 4.2, p ¼
7.243 1012) and SardiNIA (b¼ 2.2, p¼ 7.243 106), there
wasnoevidenceof association inBLSA (b¼0.36, p¼0.819).
Therewas signiﬁcant evidenceofheterogeneity (c2¼18.11,
p¼ 1.23 104) between the studies. Themost likely source
of these differences is the higher folate status in the United
States due to food fortiﬁcation. This compensation of
677C/T effect by folate status has been described in other
studies.44,45
The second and third SNPs in the homocysteine analyses
were rs11041321 (Synaptotagmin IX (SYT9 [GeneID
143425]) p ¼ 2.4 3 106; Figure S4) and rs2713280 (no
nearby genes; p ¼ 5.41 3 106), respectively. Synaptotag-
mins are calcium sensors that regulate exocytosis and
have important roles in neurotransmission.46,47 Homocys-
teine has been implicated in the pathogenesis of neurolog-
ical conditions such as dementia (MIM 600274). In light of
the potential role of SYT9 in neurotransmission,
rs11041321 was tested for replication but the association
was not conﬁrmed in Progetto nutrizione study.
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3.480 The American Journal of Human Genetics 84, 477–482, April 1No SNPs reached genome-wide signiﬁcance in the meta-
analysis of folate concentrations (Figure S1). The most
signiﬁcant rs1999594 (pmeta ¼ 1.06 3 107) is located
~100 kb from MTHFR (Figure S5). Because this SNP is in
partial LD rs1801133 (r2 ¼ 0.2 in the HapMAP CEU
sample) and did not reach genome-wide signiﬁcance, it
was tested for replication. The second SNP was rs153734
in the 30 untranslated region of the prickle-like homolog
2 gene, (PRICKLE2 [MIM 608501], Figure S5). In mice,
PRICKEL2 homolog is continuously expressed in postmi-
totic neurons in early embryogenesis and has been impli-
cated in neuron formation during brain development.48
For this observation, PRICKLE2 was a good candidate
gene in the context of folate deﬁciency and NTD. This
SNP was tested for replication in the Progetto nutrizione
study, but the association was not conﬁrmed.
Several studies have investigated the associations of
genes other than MTHFR in the OCM pathway and circu-
lating B vitamins and homocysteine concentrations. We
examine the associations of polymorphisms located in ten
candidate genes (MTHFR and MTR [MIM 156570], MTRR
[MIM 602568], MTHFD1 [MIM 172460], BHMT [MIM
602888], CBS [MIM 236200], TCN2 [MIM 275350], PON1
[MIM 168820], DHFR [MIM 126060], and FOLH1 [MIM
600934]) in the current analyses. None of these genes
were associated with vitamin B6 or vitamin B12 (data not
shown). Variants in BHMT (rs651852, p ¼ 0.003), FOLH1
(rs202700, p ¼ 0.0008), and CBS (rs2124459, p ¼ 0.0034)
showed the greatest evidence for signiﬁcance association
with folate concentrations (Table S1). For homocysteine,
MTR (rs12060264, p ¼ 0.0005), MTRR (rs7703033, p ¼
0.005), and CBS (rs6586282, p¼ 0.0002) showed the great-
est evidence of association (Table S1).
In summary, we report two variants associated with
vitamin B6 and vitamin B12 concentrations. In addition
toMTHFR, several genes in the OCM pathway were associ-
ated with circulating folate and homocysteine. These SNPs
may be important markers to identify people at risk for life-
long low vitamin and high homocysteine levels. In partic-
ular, this may be relevant to persons at risk for vitamin
deﬁciencies such as the elderly in nursing homes. Future
studies may investigate the potentially additive nature of
multiple polymorphisms of genes in the OCM pathway
on homocysteine concentrations and test the hypothesis
that polymorphisms in these genes are risk factors for
subclinical B vitamin deﬁciency and its consequences.
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found with this article online at http://www.ajhg.org/.
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